Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 2/20 | 0.36 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | ESPL1 | Q14674 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | GUSB | P08236 | 1/20 | 0.31 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.31 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28363043 | 0.89 | MAPT (0.37) | PGRMAPTLMNAGUSB | |
| SCHEMBL21635540 | 0.86 | ESPL1 (0.37) | AKR1B1PGRHSP90AA1ESPL1MAPT | |
| SCHEMBL25166724 | 0.83 | FFAR4 (0.35) | AKR1B1FFAR4CA1CA2ITGB1 | |
| SCHEMBL22714339 | 0.83 | MAPT (0.36) | AKR1B1PGRHSP90AA1ESPL1MAPT | |
| SCHEMBL29438153 | 0.83 | MAPT (0.36) | AKR1B1PGRHSP90AA1ESPL1MAPT | |
| SCHEMBL22714353 | 0.80 | CA1 (0.41) | AKR1B1PGRHSP90AA1ESPL1MAPT | |
| SCHEMBL29438166 | 0.80 | CA1 (0.41) | AKR1B1PGRHSP90AA1ESPL1MAPT | |
| SCHEMBL21635547 | 0.79 | MAPT (0.38) | MAPTLMNACA1CA2ITGB1 | |
| SCHEMBL29438157 | 0.79 | MAPT (0.38) | MAPTLMNACA1CA2ITGB1 | |
| SCHEMBL25061603 | 0.77 | MAPT (0.38) | AKR1B1MAPTGUSBNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303545-A1 | PREPARATION METHOD OF PHENYLISOXAZOLINE COMPOUND | SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) | 2023-09-28 | — | — | US | disclosed |
| EP-4177250-A1 | PREPARATION METHOD FOR PHENYLISOXAZOLINE COMPOUND | Shenyang Sinochem Agrochemicals R & D Co., Ltd. (CN) | 2023-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303545-A1 | PREPARATION METHOD OF PHENYLISOXAZOLINE COMPOUND | UMPS, UGT1A7, UGT2B7 | AKR1B1 2305/4885PGR 3094/4885HSP90AA1 4369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.